Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

Not Applicable

Completed

• Conditions: HIV Infections; Herpes Simplex

• Registration Number: NCT00002181
• Lead Sponsor: Gilead Sciences

Brief Summary

The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.

Detailed Description

Patients receive open-label treatment with cidofovir gel.

Study Timeline

• Status Verified: 1997-11
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (15)

Mem Med Group Inc; 🇺🇸 Long Beach, California, United States

AIDS Healthcare Foundation Labs; 🇺🇸 Los Angeles, California, United States

Sharp Mission Park / Med Group; 🇺🇸 Oceanside, California, United States

Park Ctr for Health / Keith Vrhel; 🇺🇸 San Diego, California, United States

Potrero Hill Med Ctr; 🇺🇸 San Francisco, California, United States

HIV Primary Care & Consult; 🇺🇸 Santa Rosa, California, United States

Central Florida Research Initiative; 🇺🇸 Maitland, Florida, United States

Braude Mermin Spivey MD PC; 🇺🇸 Atlanta, Georgia, United States

Christie Clinic / Urbana Campus; 🇺🇸 Urbana, Illinois, United States

Heywood Memorial Hosp; 🇺🇸 Gardner, Massachusetts, United States

Scroll for more (5 remaining)